Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 7/20 | 0.68 |
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.68 |
| ▸ | CRHBP | P24387 | 1/20 | 0.68 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.48 |
| ▸ | USP2 | O75604 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | PARP1 | P09874 | 2/20 | 0.46 |
| ▸ | RGS12 | O14924 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015438 | 0.92 | KEAP1 (0.70) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL503227 | 0.82 | KEAP1 (1.00) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL24284572 | 0.82 | L3MBTL1 (0.43) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL12179718 | 0.81 | HKDC1 (0.48) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL76969 | 0.80 | L3MBTL1 (0.56) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL10015445 | 0.80 | KEAP1 (0.66) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL10015439 | 0.79 | KEAP1 (0.61) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL30309289 | 0.79 | KEAP1 (0.57) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL18045745 | 0.78 | L3MBTL1 (0.55) | KEAP1NFE2L2CRHBPCRHR2KMT2A | |
| SCHEMBL14701776 | 0.78 | HKDC1 (0.44) | KEAP1NFE2L2CRHBPCRHR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315460-B2 | Organic compound, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2016-04-19 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-8940413-B2 | Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus | CANON KABUSHIKI KAISHA (JP) | 2015-01-27 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374738-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KK (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120025183-A1 | NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS | ACE, ACE2, AGTR1 | KEAP1 291/4885NFE2L2 2170/4885CRHBP 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.